Cytotoxic and Allergenic Potential of Bioactive Proteins and Peptides
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
897-920
Author(s):
Rainer Hartmann, Jean-Michel Wal, Herve Bernard and Anne-Kathrin Pentzien
CD40L - A Multipotent Molecule for Tumor Therapy
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
7
Page:
23-28
Author(s):
Angelica Loskog and Thomas H. Totterman
Critical Enzymes Involved in Endocannabinoid Metabolism
Journal:
Protein & Peptide Letters
Volume:
14
Page:
237-246
Author(s):
Balapal S. Basavarajappa
Silybin and Silymarin - New and Emerging Applications in Medicine
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
315-338
Author(s):
Radek Gazak, Daniela Walterova and Vladimir Kren
The HOX Gene Network as a Potential Target for Cancer Therapy
Journal:
Current Cancer Therapy Reviews
Volume:
3
Page:
17-24
Author(s):
Monica Cantile, Giulia Schiavo, Luigi Terracciano and Clemente Cillo
Costimulation, Coinhibition and Cancer
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
15-30
Author(s):
Brant A. Inman, Xavier Frigola, Haidong Dong and Eugene D. Kwon
Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
31-40
Author(s):
Alexander J. Muller and George C. Prendergast
T Cell Costimulatory and Inhibitory Receptors as Therapeutic Targets for Inducing Anti-Tumor Immunity
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
55-70
Author(s):
Jeurgen Foell and Becker Hewes
Small Molecule Inhibitors of Stat3 Signaling Pathway
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
91-107
Author(s):
Jinxia Deng, Fedora Grande and Nouri Neamati
Novel Therapeutic Approaches Based on the Targeting of Microenvironment-Derived Survival Pathways in Human Cancer: Experimental Models and Translational Issues
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
487-496
Author(s):
Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Teresa Fulciniti, Maria Teresa Di Martino and Salvatore Venuta